Lv1
38 积分 2024-05-28 加入
Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab
2天前
已完结
Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab
2天前
已完结
Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab
2天前
已完结
Secondary solid cancer screening following hematopoietic cell transplantation
2天前
已完结
[18F]FDG PET/CT for prognosis and toxicity prediction of diffuse large B-cell lymphoma patients with chimeric antigen receptor T-cell therapy
2天前
已完结
Risk of secondary T-cell malignancy after CAR T-cell therapy
13天前
已完结
Secondary solid cancer screening following hematopoietic cell transplantation
13天前
已完结
ITK Gene Mutation: Effect on Survival of Children with Severe Hemophagocytic Lymphohistiocytosis
1个月前
已完结
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas
1个月前
已完结
Manufacturing CAR T Therapies: A Review of Methods, Controls, and Innovations for Scalable, Accessible Treatments
1个月前
已完结
皖公网安备34019202002308
